Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium phosphocreatine for perioperative myocardial protection in peritoneal dialysis catheterization
ChiCTR2000040905Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jan 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of phosphocreatine in kidney failure and Myocardial injury (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoints: blood pressure, heart rate and 2 more. Started Jan 2021; status: recruiting.
02
Drugs
phosphocreatine
03
Conditions
kidney failureMyocardial injury
Beyond the preview
Go deeper on ChiCTR2000040905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040905.